Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Enforcement of a new data protection law in Europe: A threat and an opportunity for registries and cohorts in the field of rare diseases].

La Revue de medecine interne·2018
Same author

The potential benefits of genetic testing in breast and ovarian cancer.

Saudi medical journal·2016
Same author

Quantifying benefit-risk preferences for new medicines in rare disease patients and caregivers.

Orphanet journal of rare diseases·2016
Same author

[Concepts for the return of secondary genetic findings in medical diagnostics and research].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2014
Same author

Health needs assessment for medical genetic services for congenital disorders in middle- and low-income nations.

Journal of community genetics·2013
Same author

International variation in physicians' attitudes towards prophylactic mastectomy - comparison between France, Germany, the Netherlands and the United Kingdom.

European journal of cancer (Oxford, England : 1990)·2013

Related Experiment Video

Updated: Jul 10, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Networking for rare diseases: a necessity for Europe.

S Aymé1, J Schmidtke

  • 1Inserm, Orphanet Paris, Paris, France. ayme@orpha.net

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|November 21, 2007
PubMed
Summary

Addressing rare diseases requires a unified approach. Initiatives like Orphanet and funded research networks are improving diagnosis, care, and quality of life for patients with these genetic conditions.

Area of Science:

  • Public Health
  • Genetics
  • Medical Research

Background:

  • Rare diseases are often life-threatening, genetically determined, and chronically debilitating.
  • Low individual prevalence necessitates collaborative efforts for diagnosis, care, and prevention.
  • A global approach is more feasible than disease-specific policies for rare conditions.

Purpose of the Study:

  • To present successful initiatives addressing rare diseases at the European Union (EU) and Member State levels.
  • To highlight strategies for improving scientific research, drug development, and patient care for rare conditions.

Main Methods:

  • Establishment of Orphanet: a comprehensive database for rare diseases and orphan drugs.
  • Funding of research networks to foster collaboration among scientific teams.

More Related Videos

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Related Experiment Videos

Last Updated: Jul 10, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

  • Support for networks of clinical centers of reference to enhance patient services and clinical research.
  • Main Results:

    • Orphanet provides an encyclopedia of rare diseases and a directory of expert services.
    • Funded research networks are boosting collaboration between research teams.
    • Networks of clinical centers of reference are improving patient care and clinical research development.

    Conclusions:

    • EU and Member State initiatives have proven effective in developing solutions for rare diseases.
    • These initiatives positively impact patients' quality of life.
    • A coordinated, global strategy is essential for advancing rare disease research and care.